Glycopyrrolate Injection
Product Images NDC 55154-7475

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 55154-7475). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

88945f94 Fad0 454b B72d 8ec2a8ab7cd8 00

Label for Glycopyrrolate Injection, USP 0.2 mg/mL in 5 x 1 mL single dose vials. The label includes warnings such as 'Not for use in newborns' and indicates it contains benzyl alcohol as a preservative. Directions mention use for intramuscular or intravenous administration. Manufactured by HIKMA Farmacêutica (Portugal) S.A. and distributed by West-Ward and Cardinal Health, USA. Storage instructions specify controlled room temperature.*

FDA Label Image

Glycopyrrolate Injection 1

Chemical structure of Glycopyrrolate showing its molecular composition with carbon, hydrogen, oxygen, nitrogen atoms, and bromide ion. The molecular formula (C19H28BrNO3) and molecular weight (398.33) are also displayed.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.